Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period

Link to article at PubMed

JAMA. 2022 Jan 20:e220210. doi: 10.1001/jama.2022.0210. Online ahead of print.


This study examines breakthrough SARS-CoV-2 infections, hospitalizations, and mortality in March-August 2021, when the Delta variant predominated, among a general US cohort vaccinated with mRNA-1273 or BNT162b2.

PMID:35050314 | PMC:PMC8778597 | DOI:10.1001/jama.2022.0210

Leave a Reply

Your email address will not be published.